300804 广康生化
未开盘 07-09 09:30:00
资讯
新帖
简况
每周股票复盘：广康生化（300804）每10股派1.50元
证券之星 · 06-21
每周股票复盘：广康生化（300804）每10股派1.50元
股市必读：广康生化（300804）6月15日董秘有最新回复
证券之星 · 06-16
股市必读：广康生化（300804）6月15日董秘有最新回复
广康生化：公司未生产您所提到的高毒农药产品
证券之星 · 06-15
广康生化：公司未生产您所提到的高毒农药产品
广康生化（300804）披露特定股东减持股份预披露公告，5月28日股价下跌2.25%
证券之星 · 05-28
广康生化（300804）披露特定股东减持股份预披露公告，5月28日股价下跌2.25%
广康生化(300804.SZ)特定股东拟减持合计不超0.608%股份
智通财经 · 05-28
广康生化(300804.SZ)特定股东拟减持合计不超0.608%股份
5月25日广康生化发布公告，股东减持86.98万股
证券之星 · 05-25
5月25日广康生化发布公告，股东减持86.98万股
广康生化：东北证券股份有限公司、前海开源基金管理有限公司等多家机构于5月22日调研我司
证券之星 · 05-25
广康生化：东北证券股份有限公司、前海开源基金管理有限公司等多家机构于5月22日调研我司
股市必读：广康生化（300804）5月18日收盘跌10.38%，主力净流出1574.67万元
证券之星 · 05-19
股市必读：广康生化（300804）5月18日收盘跌10.38%，主力净流出1574.67万元
广康生化（300804）披露2025年度股东会决议公告，5月15日股价下跌2.43%
证券之星 · 05-15
广康生化（300804）披露2025年度股东会决议公告，5月15日股价下跌2.43%
股市必读：广康生化年报 - 第四季度单季净利润同比下降46.63%
证券之星 · 04-27
股市必读：广康生化年报 - 第四季度单季净利润同比下降46.63%
广康生化（300804）2026年一季报简析：净利润同比下降103.36%，三费占比上升明显
证券之星 · 04-25
广康生化（300804）2026年一季报简析：净利润同比下降103.36%，三费占比上升明显
图解广康生化年报：第四季度单季净利润同比下降46.63%
证券之星 · 04-24
图解广康生化年报：第四季度单季净利润同比下降46.63%
广康生化(300804.SZ)：一季度净亏损57.55万元
中金财经 · 04-23
广康生化(300804.SZ)：一季度净亏损57.55万元
广康生化（300804）披露持续督导期2025年培训情况报告，3月10日股价上涨6.93%
证券之星 · 03-10
广康生化（300804）披露持续督导期2025年培训情况报告，3月10日股价上涨6.93%
广康生化：该项目设计工艺流程严格遵循国家法律法规及相关标准要求
证券之星 · 03-09
广康生化：该项目设计工艺流程严格遵循国家法律法规及相关标准要求
广康生化（300804）披露特定股东减持计划实施完毕公告，3月2日股价下跌9.16%
证券之星 · 03-02
广康生化（300804）披露特定股东减持计划实施完毕公告，3月2日股价下跌9.16%
2月27日广康生化发布公告，股东减持198万股
证券之星 · 02-27
2月27日广康生化发布公告，股东减持198万股
2月26日广康生化（300804）龙虎榜数据：机构净卖出5053.34万元
证券之星 · 02-26
2月26日广康生化（300804）龙虎榜数据：机构净卖出5053.34万元
股市必读：2月25日广康生化现1笔大宗交易 机构净买入5532.88万元
证券之星 · 02-26
股市必读：2月25日广康生化现1笔大宗交易 机构净买入5532.88万元
2月12日广康生化（300804）龙虎榜数据：机构净卖出1229.53万元
证券之星 · 02-12
2月12日广康生化（300804）龙虎榜数据：机构净卖出1229.53万元
加载更多
公司概况
公司名称：
广东广康生化科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2023-06-27
主营业务：
广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是灭菌丹、克菌丹、噻呋酰胺、土菌灵、萎锈灵、联苯肼酯、甲氧虫酰肼、甜菜宁、甜菜安、乙氧呋草黄。
发行价格：
42.45
{"stockData":{"symbol":"300804","market":"SZ","secType":"STK","nameCN":"广康生化","latestPrice":30.19,"timestamp":1783558839000,"preClose":30.19,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":27500000,"shares":74000000,"eps":0.3112,"marketStatus":"未开盘","change":0,"latestTime":"07-09 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.3112,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783560600000},"marketStatusCode":0,"adr":0,"adjPreClose":30.19,"symbolType":"stock","openAndCloseTimeList":[[1783560600000,1783567800000],[1783573200000,1783580400000]],"highLimit":33.21,"lowLimit":27.17,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":74000000,"isCdr":false,"pbRate":1.63,"roa":"--","peRate":97.011568,"roe":"--","epsLYR":0.55,"committee":0,"marketValue":2234000000,"turnoverRate":0,"status":2,"floatMarketCap":830000000},"requestUrl":"/m/hq/s/300804","defaultTab":"news","newsList":[{"id":"2645209672","title":"每周股票复盘：广康生化（300804）每10股派1.50元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645209672","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645209672?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:35","pubTimestamp":1781984112,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，广康生化报收于36.43元，较上周的38.04元下跌4.23%。本周，广康生化6月15日盘中最高价报39.5元。广康生化当前最新总市值26.96亿元，在农化制品板块市值排名47/58，在两市A股市值排名4576/5206。本次权益分派股权登记日为2026年6月24日，除权除息日为2026年6月25日。本次实施的方案与股东会审议通过的一致，且股本总额在实施前未发生变化。权益分派实施后，相关股东及董监高的最低减持价格将调整为41.63元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643078316","title":"股市必读：广康生化（300804）6月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2643078316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643078316?lang=zh_cn&edition=full","pubTime":"2026-06-16 03:30","pubTimestamp":1781551832,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘，广康生化报收于37.53元，下跌1.34%，换手率5.73%，成交量1.58万手，成交额6031.45万元。董秘最新回复投资者： 6月1日，氧乐果、克百威、灭多威、涕灭威4种高毒农药全面禁止销售和使用。关于氯虫苯甲酰胺，公司目前也未生产该产品。当日关注点交易信息汇总：6月15日主力资金净流出69.06万元，游资资金净流出393.77万元，散户资金净流入462.82万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600004454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643827537","title":"广康生化：公司未生产您所提到的高毒农药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2643827537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643827537?lang=zh_cn&edition=full","pubTime":"2026-06-15 15:51","pubTimestamp":1781509874,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问：6月1日，氧乐果、克百威、灭多威、涕灭威4种高毒农药全面禁止销售和使用。至此，加上2024年9月已退市的甲拌磷、甲基异柳磷、水胺硫磷、灭线磷，两年间已有8种高毒农药彻底告别市场，全国禁用农药品种达到约60种。请问上述产品禁用对公司生产、经营有没有影响？氯虫苯甲酰胺能不能替代上述产品？广康生化回复：您好，公司未生产您所提到的高毒农药产品，相关禁用政策对公司生产、经营没有影响。关于氯虫苯甲酰胺，公司目前也未生产该产品。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500015571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638694623","title":"广康生化（300804）披露特定股东减持股份预披露公告，5月28日股价下跌2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638694623","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638694623?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:45","pubTimestamp":1779979512,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，广康生化报收于38.63元，较前一交易日下跌2.25%，最新总市值为28.59亿元。该股当日开盘39.55元，最高39.76元，最低37.87元，成交额达5068.72万元，换手率为4.77%。近日，广东广康生化科技股份有限公司发布《关于特定股东减持股份的预披露公告》。减持原因为自身资金需求，股份来源为首次公开发行前取得的股份及二级市场购回股份，减持价格将根据市场价格确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638693843","title":"广康生化(300804.SZ)特定股东拟减持合计不超0.608%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2638693843","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638693843?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:15","pubTimestamp":1779970512,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广康生化(300804.SZ)发布公告，特定股东共青城华拓至盈贰号投资合伙企业(有限合伙)(以下简称“华拓至盈贰号”)以及深圳市华拓至远叁号投资企业(有限合伙)(以下合称“华拓至远叁号”)计划自本公告披露之日起三个交易日后的三个月内，通过集中竞价交易方式减持公司股份。其中，华拓至盈贰号计划减持不超过39万股，即不超过公司总股本的0.5270%;华拓至远叁号计划减持不超过6万股，即不超过公司总股本的0.0811%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638558052","title":"5月25日广康生化发布公告，股东减持86.98万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638558052","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638558052?lang=zh_cn&edition=full","pubTime":"2026-05-25 21:00","pubTimestamp":1779714055,"startTime":"0","endTime":"0","summary":"证券之星消息，5月25日广康生化发布公告《广康生化:关于特定股东减持股份计划期限届满暨实施情况的公告》，其股东共青城华拓至盈贰号投资合伙企业(有限合伙)、深圳市华拓至远叁号投资企业(有限合伙)于2026年2月25日至2026年2月27日间合计减持86.98万股，占公司目前总股本的1.1754%，变动期间该股股价上涨16.13%，截止2月27日收盘报52.71元。股东增减持详情见下表：根据广康生化2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500032185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638538256","title":"广康生化：东北证券股份有限公司、前海开源基金管理有限公司等多家机构于5月22日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2638538256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638538256?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:13","pubTimestamp":1779693231,"startTime":"0","endTime":"0","summary":"公司现有在建的硝化装置是经过国家批准的少数项目之一。受地缘冲突等因素影响，部分原材料成本有所上涨，公司克菌丹、灭菌丹等产品已根据市场情况进行了适度提价。后续价格走势将视原材料成本、市场供需等因素动态调整。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500014966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000686","BK0188","BK0183","BK0229","BK0276","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636008589","title":"股市必读：广康生化（300804）5月18日收盘跌10.38%，主力净流出1574.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636008589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636008589?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:12","pubTimestamp":1779124331,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，广康生化报收于45.06元，下跌10.38%，换手率15.98%，成交量4.39万手，成交额2.06亿元。交易信息汇总股价提醒5月18日广康生化收盘报45.06元，跌10.38%，当日成交439.46万元。前10个交易日资金流向情况：主力资金累计净流出8044.87万元，股价累计下跌10.41%；融资余额累计减少1848.4万元，融券余量累计增加100股。资金流向5月18日主力资金净流出1574.67万元；游资资金净流入1240.8万元；散户资金净流入333.87万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900001833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635746700","title":"广康生化（300804）披露2025年度股东会决议公告，5月15日股价下跌2.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635746700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635746700?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:44","pubTimestamp":1778838258,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，广康生化报收于50.28元，较前一交易日下跌2.43%，最新总市值为37.21亿元。该股当日开盘51.3元，最高53.26元，最低49.76元，成交额达1.57亿元，换手率为11.13%。近日，广东广康生化科技股份有限公司发布《2025年度股东会决议公告》。公告显示，公司于2026年5月14日召开2025年度股东会，会议由董事会召集，董事长蔡丹群主持，采用现场与网络投票结合方式召开。出席会议股东及代表共41人，代表有表决权股份47,190,000股，占公司总股份的63.7703%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500034427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630369323","title":"股市必读：广康生化年报 - 第四季度单季净利润同比下降46.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630369323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630369323?lang=zh_cn&edition=full","pubTime":"2026-04-27 03:25","pubTimestamp":1777231513,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年3月31日股东户数环比下降13.85%，户均持股数量升至9826.0股。来自业绩披露要点：2025年扣非净利润同比增长65.12%，但第四季度归母净利润同比下降46.63%。股本股东变化股东户数变动近日广康生化披露，截至2026年3月31日公司股东户数为7531.0户，较12月31日减少1211.0户，减幅为13.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700005444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630873987","title":"广康生化（300804）2026年一季报简析：净利润同比下降103.36%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2630873987","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630873987?lang=zh_cn&edition=full","pubTime":"2026-04-25 06:33","pubTimestamp":1777070036,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广康生化发布2026年一季报。截至本报告期末，公司营业总收入1.6亿元，同比下降14.33%，归母净利润-57.55万元，同比下降103.36%。本报告期广康生化三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达33.87%。去年的净利率为5.35%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500021826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629854832","title":"图解广康生化年报：第四季度单季净利润同比下降46.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629854832","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629854832?lang=zh_cn&edition=full","pubTime":"2026-04-24 01:23","pubTimestamp":1776965003,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化2025年年报显示，当年度公司主营收入7.55亿元，同比上升4.33%；归母净利润4071.33万元，同比上升17.39%；扣非净利润3806.48万元，同比上升65.12%；其中2025年第四季度，公司单季度主营收入2.05亿元，同比下降14.3%；单季度归母净利润586.5万元，同比下降46.63%；单季度扣非净利润565.42万元，同比下降48.71%；负债率38.3%，投资收益636.8万元，财务费用1834.76万元，毛利率24.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400003427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629856359","title":"广康生化(300804.SZ)：一季度净亏损57.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629856359","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629856359?lang=zh_cn&edition=full","pubTime":"2026-04-23 23:37","pubTimestamp":1776958621,"startTime":"0","endTime":"0","summary":"格隆汇4月23日丨广康生化(300804.SZ)发布2026年一季度报告，报告期内，实现营业收入1.60亿元，同比下降14.33%；归属于上市公司股东的净利润-57.55万元，归属于上市公司股东的扣除非经常性损益的净利润-137.48万元，基本每股收益-0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260423/32169134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618959625","title":"广康生化（300804）披露持续督导期2025年培训情况报告，3月10日股价上涨6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618959625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618959625?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:14","pubTimestamp":1773152061,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，广康生化报收于49.4元，较前一交易日上涨6.93%，最新总市值为36.56亿元。该股当日开盘45.7元，最高49.68元，最低45.4元，成交额达2.26亿元，换手率为17.27%。近日，广康生化披露《华泰联合证券有限责任公司关于广东广康生化科技股份有限公司持续督导期2025年培训情况报告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618645197","title":"广康生化：该项目设计工艺流程严格遵循国家法律法规及相关标准要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2618645197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618645197?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:03","pubTimestamp":1773043387,"startTime":"0","endTime":"0","summary":"投资者提问：公司在建《年产25458吨特种新材料建设项目》，请问设计工艺流程是否符合《硝化工艺安全技术规范》、《安全生产行业标准：精细化工企业安全管理规范》等要求？公司年产25458吨特种新材料建设项目项下在建产品正如期推进中，该项目设计工艺流程严格遵循国家法律法规及相关标准要求，未来项目投产后，产品将部分自用、部分外销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900019176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616038034","title":"广康生化（300804）披露特定股东减持计划实施完毕公告，3月2日股价下跌9.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616038034","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616038034?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:41","pubTimestamp":1772444465,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，广康生化报收于47.88元，较前一交易日下跌9.16%，最新总市值为35.43亿元。该股当日开盘51.0元，最高52.45元，最低45.51元，成交额达3.95亿元，换手率为29.71%。本次减持后，该股东不再持有公司股份。减持计划已实施完毕，且符合相关法律法规及监管规定，未违反此前承诺，不影响公司控制权稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200026424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614685864","title":"2月27日广康生化发布公告，股东减持198万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614685864","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614685864?lang=zh_cn&edition=full","pubTime":"2026-02-27 20:02","pubTimestamp":1772193745,"startTime":"0","endTime":"0","summary":"证券之星消息，2月27日广康生化发布公告《广康生化:关于特定股东减持计划实施完毕的公告》，其股东共青城瑞宏凯银壹号股权投资基金合伙企业(有限合伙)于2026年2月25日至2026年2月26日间合计减持198.0万股，占公司目前总股本的2.6757%，变动期间该股股价上涨14.3%，截止2月26日收盘报51.88元。股东增减持详情见下表：根据广康生化2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700037258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614019866","title":"2月26日广康生化（300804）龙虎榜数据：机构净卖出5053.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614019866","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614019866?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:21","pubTimestamp":1772097710,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年2月26日公布的交易公开信息显示，广康生化因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年2月26日收盘，广康生化报收于51.88元，上涨14.53%，换手率39.02%，成交量10.73万手，成交额5.2亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出5053.34万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614037787","title":"股市必读：2月25日广康生化现1笔大宗交易 机构净买入5532.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614037787","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614037787?lang=zh_cn&edition=full","pubTime":"2026-02-26 01:55","pubTimestamp":1772042112,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘，广康生化报收于45.3元，下跌0.2%，换手率20.64%，成交量5.68万手，成交额2.58亿元。当日关注点来自交易信息汇总：2月25日主力资金净流出244.32万元，散户资金净流入1583.7万元。大宗交易2月25日广康生化现1笔大宗交易，机构净买入5532.88万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600001032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610394600","title":"2月12日广康生化（300804）龙虎榜数据：机构净卖出1229.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610394600","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610394600?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:39","pubTimestamp":1770889199,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年2月12日公布的交易公开信息显示，广康生化因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年2月12日收盘，广康生化报收于45.87元，上涨4.23%，换手率33.15%，成交量9.12万手，成交额4.09亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出1229.53万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200028900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783558869751,"stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":-0.1627},{"period":"3month","weight":-0.416},{"period":"6month","weight":-0.1568},{"period":"1year","weight":-0.3924},{"period":"ytd","weight":-0.1337}],"compareEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0012},{"period":"6month","weight":-0.0363},{"period":"1year","weight":0.1354},{"period":"ytd","weight":0.0005}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东广康生化科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"7531人(较上一季度减少13.85%)","perCapita":"3651股","listingDate":"2023-06-27","address":"广东省清远市英德市农用化工产业链专用基地(英德市沙口镇红丰管理区)","registeredCapital":"7400万元","survey":" 广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是灭菌丹、克菌丹、噻呋酰胺、土菌灵、萎锈灵、联苯肼酯、甲氧虫酰肼、甜菜宁、甜菜安、乙氧呋草黄。","listedPrice":42.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广康生化,300804,广康生化股票,广康生化股票老虎,广康生化股票老虎国际,广康生化行情,广康生化股票行情,广康生化股价,广康生化股市,广康生化股票价格,广康生化股票交易,广康生化股票购买,广康生化股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}